Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice.
| Author | |
|---|---|
| Abstract | 
   :  
              Binge eating disorder (BED) is the most common eating disorder and was newly recognized in 2013 in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). BED is frequently associated with obesity and the metabolic syndrome, as well as with other psychiatric diseases, such as mood (49%), anxiety (41%), and substance use (22%) disorders. BED is highly prevalent and carries a high burden of mental and physical illness and disability. However, BED is frequently under-recognized and under-treated.  | 
        
| Year of Publication | 
   :  
              2019 
           | 
        
| Journal | 
   :  
              Expert opinion on pharmacotherapy 
           | 
        
| Volume | 
   :  
              20 
           | 
        
| Issue | 
   :  
              6 
           | 
        
| Number of Pages | 
   :  
              679-690 
           | 
        
| ISSN Number | 
   :  
              1465-6566 
           | 
        
| URL | 
   :  
              http://www.tandfonline.com/doi/full/10.1080/14656566.2019.1571041 
           | 
        
| DOI | 
   :  
              10.1080/14656566.2019.1571041 
           | 
        
| Short Title | 
   :  
              Expert Opin Pharmacother 
           | 
        
| Download citation |